AV Ramana, chairman, NMPA, presided over the function and inaugurated the event along with S Shanthi, deputy chairperson, and Padmanabhachar K, IOFS, CVO, NMPA. 1,500 Alva's students join Yoga ...

The NMPA Annual Meeting will feature an artist lineup that includes Gracie Abrams, Thomas Rhett, Aaron Dessner, Leon Bridges ...

Mangaluru: TK Ramachandran, secretary of ministry of ports, shipping & waterways (MoPSW), inaugurated a newly constructed Security Surveillance To.

China’s National Medical Products Administration (NMPA) has accepted for review Carsgen Therapeutics Holdings Ltd.’s NDA for satricabtagene autoleucel (satri-cel, CT-041), an autologous CAR T ...

The Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has granted BioCity's endothelin receptor type A (ET A) antagonist, SC0062, a second breakthrough ...

Company News Published 06/30/2025, 08:25 AM 0 Tempest gets NMPA approval for pivotal trial of liver cancer drug TPST 0.00% ...

YUPELRI approved by China's NMPA as the first once-daily nebulized LAMA for maintenance treatment of COPD Approval triggers $7.5 million milestone payment from Viatris, with eligibility to receive ...

China NMPA approves Hutchmed’s Orpathys in combo with Tagrisso to treat lung cancer patients with MET amplification after progression on first-line EGFR inhibitor therapy Hong Kong, Shanghai Tuesday, ...

HUTCHMED announces NMPA approval for ORPATHYS® and TAGRISSO® combination therapy for advanced lung cancer, showing significant efficacy. Quiver AI Summary HUTCHMED has announced the approval of ...

CARsgen Therapeutics Holdings Limited, a company focused on developing innovative CAR T-cell therapies, announces that the National Medical Products Administration (NMPA) of China has accepted the New ...

“As a company, we look at music as art, and we would never want to give away art for free. It makes no sense to me,” Apple Music head Oliver Schusser said during a keynote at the NMPA’s ...

SHANGHAI, June 10, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that the China National Medical Products Administration (NMPA) has accepted the New Drug ...